{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:24:29Z","timestamp":1774293869882,"version":"3.50.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>We provided cancer mortality rate estimates for the year 2025 in six Latin American countries (Argentina, Brazil, Chile, Colombia, Cuba, and Mexico), focusing on prostate cancer. We extracted mortality data for all cancers combined and the most common sites from the WHO and population data since 1970 from the United Nations. Estimates for 2025 were computed applying a linear regression to the most recent segment identified through Poisson join-point regression. Avoided deaths number from 1991 to 2025 was estimated by applying the 1990 peak rate to population data. Mortality from all cancers is predicted to be favorable for both sexes in all countries. The lowest total cancer mortality rates are expected in Mexico (67.7\/100\u2005000 males; 61.4\/100\u2005000 females), while the highest ones in Cuba (136.6\/100\u2005000 males; 91.6\/100\u2005000 females). Prostate cancer mortality is declining in all countries, although rates remain high in Cuba (25.2\/100\u2005000 in 2025). Downward patterns are observed for all age groups in all countries, except the elderly in Cuba and Mexico. Declines in mortality are predicted for colorectal (except for males in Brazil and Cuba, and females in Chile), stomach (except Cuban males), pancreatic (except Argentinian and Cuban males), lung, bladder (except Argentinian females), breast, and ovarian (except Cuba) cancers. Uterine cancer mortality, particularly from cervical cancer, remains highin Argentina (10.2\/100\u2005000) and Cuba (10.4\/100\u2005000). Except for uterine, stomach, and prostate cancers, cancer mortality rates are still relatively low in Latin America, except Cuba. Controlling tobacco particularly in Cuba, implementing organized cervical cancer screening, and advancing cancer treatment also for prostate cancer remain crucial in all countries considered.<\/jats:p>","DOI":"10.1097\/cej.0000000000000959","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T12:00:48Z","timestamp":1741003248000},"page":"97-107","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Cancer mortality predictions for 2025 in Latin America with focus on prostate cancer"],"prefix":"10.1097","volume":"35","author":[{"given":"Silvia","family":"Mignozzi","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Santucci","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Levi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Services Research, Centre for Primary Care and Public Health (Unisant\u00e9), University of Lausanne, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Malvezzi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Boffetta","sequence":"additional","affiliation":[{"name":"Department of Family, Population & Preventive Medicine, Stony Brook University, Stony Brook, New York, USA"},{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Corso","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)"},{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Negri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"R1-20260130","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.1038\/s41598-023-38437-7","article-title":"An appraisal of the principal concerns and controlling factors for Arsenic contamination in Chile.","volume":"13","author":"Alam","year":"2023","journal-title":"Sci Rep"},{"key":"R2-20260130","doi-asserted-by":"crossref","first-page":"e2400072","DOI":"10.1200\/GO.24.00072","article-title":"Genomic landscape in prostate cancer in a Latin American population.","volume":"10","author":"Angel","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"R3-20260130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.euo.2021.05.005","article-title":"Mortality trends from urologic cancers in Europe over the period 1980\u20132017 and a projection to 2025.","volume":"4","author":"Bertuccio","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"R4-20260130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2105\/AJPH.2013.301844","article-title":"National trends in smoking behaviors among Mexican, Puerto Rican, and Cuban men and women in the United States.","volume":"104","author":"Blanco","year":"2014","journal-title":"Am J Public Health"},{"key":"R5-20260130","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/annonc\/mdx301","article-title":"Cancer mortality predictions for 2017 in Latin America.","volume":"28","author":"Carioli","year":"2017","journal-title":"Ann Oncol"},{"key":"R6-20260130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ijc.32749","article-title":"Cancer mortality predictions for 2019 in Latin America.","volume":"147","author":"Carioli","year":"2020","journal-title":"Int J Cancer"},{"key":"R7-20260130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/CEJ.0000000000000702","article-title":"Cancer mortality predictions for 2021 in Latin America.","volume":"31","author":"Carioli","year":"2022","journal-title":"Eur J Cancer Prev"},{"key":"R8-20260130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022.","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"R9-20260130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/16078454.2020.1833504","article-title":"Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries.","volume":"25","author":"Chiattone","year":"2020","journal-title":"Hematology"},{"key":"R10-20260130","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1002\/cam4.5685","article-title":"Trends in gastric cancer mortality 1990\u20132019 in 36 countries worldwide, with predictions to 2025, and incidence, overall and by subtype.","volume":"12","author":"Collatuzzo","year":"2023","journal-title":"Cancer Med"},{"key":"R11-20260130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","article-title":"Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.","volume":"53","author":"Conti","year":"2021","journal-title":"Nat Genet"},{"key":"R12-20260130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canep.2019.04.003","article-title":"Prevalence of Helicobacter pylori infection in Latin America and the Caribbean populations: a systematic review and meta-analysis.","volume":"60","author":"Curado","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"R13-20260130","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endrev\/bnab002","article-title":"Hormonal therapy for prostate cancer.","volume":"42","author":"Desai","year":"2021","journal-title":"Endocr Rev"},{"key":"R15-20260130","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s42255-024-00977-1","article-title":"Determinants of obesity in Latin America.","volume":"6","author":"Ferreira","year":"2024","journal-title":"Nat Metab"},{"key":"R16-20260130","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1136\/gutjnl-2020-320839","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis.","volume":"69","author":"Ford","year":"2020","journal-title":"Gut"},{"key":"R17-20260130","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer.","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"R18-20260130","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2217\/fon-2020-1152","article-title":"FLABRA, frontline approach for BRCA testing in an ovarian cancer population: a Latin America epidemiologic study.","volume":"17","author":"Giornelli","year":"2021","journal-title":"Future Oncol"},{"key":"R19-20260130","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1038\/s41598-020-59056-6","article-title":"Anthropometry, body shape in early-life and risk of premenopausal breast cancer among Latin American women: results from the PRECAMA study.","volume":"10","author":"His","year":"2020","journal-title":"Sci Rep"},{"key":"R20-20260130","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis.","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"R21-20260130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer.","volume":"21","author":"Hu","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R22-20260130","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/jpm14090992","article-title":"Risk factors for ovarian cancer in South America: a literature review.","volume":"14","author":"Jara-Rosales","year":"2024","journal-title":"J Pers Med"},{"key":"R23-20260130","doi-asserted-by":"crossref","first-page":"136071","DOI":"10.1016\/j.scitotenv.2019.136071","article-title":"Health effects of arsenic exposure in Latin America: an overview of the past eight years of research.","volume":"710","author":"Khan","year":"2020","journal-title":"Sci Total Environ"},{"key":"R24-20260130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R25-20260130","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/sim.9407","article-title":"Twenty years since Joinpoint 1.0: two major enhancements, their justification, and impact.","volume":"41","author":"Kim","year":"2022","journal-title":"Stat Med"},{"key":"R26-20260130","doi-asserted-by":"crossref","first-page":"m3773","DOI":"10.1136\/bmj.m3773","article-title":"Treatment of epithelial ovarian cancer.","volume":"371","author":"Kuroki","year":"2020","journal-title":"BMJ"},{"key":"R27-20260130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors.","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"R28-20260130","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.scitotenv.2019.04.262","article-title":"Arsenic in Argentina: occurrence, human health, legislation and determination.","volume":"676","author":"Litter","year":"2019","journal-title":"Sci Total Environ"},{"key":"R29-20260130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejca.2018.09.007","article-title":"Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: a comprehensive review and meta-analysis.","volume":"104","author":"Lugo","year":"2018","journal-title":"Eur J Cancer"},{"key":"R30-20260130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41574-020-00411-y","article-title":"Nearly a decade on \u2013 trends, risk factors and policy implications in global obesity.","volume":"16","author":"Malik","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R31-20260130","doi-asserted-by":"crossref","first-page":"e2354256","DOI":"10.1001\/jamanetworkopen.2023.54256","article-title":"Colorectal cancer screening programs in Latin America: a systematic review and meta-analysis.","volume":"7","author":"Montalvan-Sanchez","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R32-20260130","doi-asserted-by":"crossref","first-page":"100536","DOI":"10.1016\/j.esmoop.2022.100536","article-title":"Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?","volume":"7","author":"Musacchio","year":"2022","journal-title":"ESMO Open"},{"key":"R33-20260130","doi-asserted-by":"crossref","first-page":"1073274820915720","DOI":"10.1177\/1073274820915720","article-title":"Prostate cancer in Latin America: challenges and recommendations.","volume":"27","author":"Reis","year":"2020","journal-title":"Cancer Control"},{"key":"R34-20260130","doi-asserted-by":"crossref","first-page":"13109","DOI":"10.1038\/s41598-018-31393-7","article-title":"Reproductive factors and molecular subtypes of breast cancer among premenopausal women in Latin America: the PRECAMA study.","volume":"8","author":"Romieu","year":"2018","journal-title":"Sci Rep"},{"key":"R35-20260130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/CEJ.0000000000000806","article-title":"Cancer mortality predictions for 2023 in Latin America with focus on stomach cancer.","volume":"32","author":"Santucci","year":"2023","journal-title":"Eur J Cancer Prev"},{"key":"R36-20260130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.annonc.2023.12.003","article-title":"European cancer mortality predictions for the year 2024 with focus on colorectal cancer.","volume":"35","author":"Santucci","year":"2024","journal-title":"Ann Oncol"},{"key":"R37-20260130","article-title":"Trends in cancer mortality under age 50 in 15 upper-middle and high-income countries.","author":"Santucci","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"R38-20260130","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update.","author":"Schafer","year":"2024","journal-title":"Eur Urol"},{"key":"R39-20260130","first-page":"12","article-title":"Cancer statistics, 2024.","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R40-20260130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","article-title":"Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data.","volume":"26","author":"Sung","year":"2025","journal-title":"Lancet Oncol"},{"issue":"Suppl 3","key":"R41-20260130","first-page":"E3","article-title":"Regional trends in the use of short-acting and long-acting contraception accessed through the private and public sectors.","volume":"130","author":"Ugaz","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"R43-20260130","first-page":"210","article-title":"Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy.","volume":"10","author":"Wang","year":"2022","journal-title":"Am J Clin Exp Urol"},{"key":"R46-20260130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOU.0000000000001124","article-title":"Optimal combination therapy for metastatic hormone-sensitive prostate cancer: new evidence, challenges and unanswered questions.","volume":"33","author":"Zattoni","year":"2023","journal-title":"Curr Opin Urol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:00:25Z","timestamp":1769752825000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000959","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}